Yu Shan
Founder presso SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Patrimonio netto: 54 M $ in data 31/03/2024
Profilo
Yu Shan ha fondato la Shenzhen Hepalink Pharmaceutical Group Co. Attualmente è direttore generale e direttore esecutivo di Shenzhen Hepalink Pharmaceutical Group Co., Ltd. e partner esecutivo di Urumqi Shuidishichuan Equity Investment Partnership LP. È anche nel consiglio di amministrazione di Chengdu Hepatunn Pharmaceutical Co. Ltd. e Shenzhen Duopule Industrial Development Co. Si è laureato all'Università di Pechino.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2023 | 46 425 600 ( 3.72% ) | 54 M $ | 31/03/2024 |
Posizioni attive di Yu Shan
| Società | Posizione | Inizio |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21/04/1998 |
| Urumqi Shuidishichuan Equity Investment Partnership LP | Corporate Officer/Principal | - |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
 Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Director/Board Member | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Director/Board Member | 13/01/2014 |
Formazione di Yu Shan
| Peking University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
| Urumqi Shuidishichuan Equity Investment Partnership LP | |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
- Borsa valori
- Insiders
- Yu Shan
